网站大量收购独家精品文档,联系QQ:2885784924

a novel inhibitor of hypoxia-inducible factor-1α p3155 also modulates pi3k pathway and inhibits growth of prostate cancer cells一种新型抑制剂的低氧factor-1αp3155也调节pi3k通路,抑制前列腺癌细胞的生长.pdfVIP

a novel inhibitor of hypoxia-inducible factor-1α p3155 also modulates pi3k pathway and inhibits growth of prostate cancer cells一种新型抑制剂的低氧factor-1αp3155也调节pi3k通路,抑制前列腺癌细胞的生长.pdf

  1. 1、本文档共10页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
a novel inhibitor of hypoxia-inducible factor-1α p3155 also modulates pi3k pathway and inhibits growth of prostate cancer cells一种新型抑制剂的低氧factor-1αp3155也调节pi3k通路,抑制前列腺癌细胞的生长

Manohar et al. BMC Cancer 2011, 11:338 /1471-2407/11/338 RESEARCH ARTICLE Open Access A novel inhibitor of hypoxia-inducible factor-1a P3155 also modulates PI3K pathway and inhibits growth of prostate cancer cells 1† 1† 1 1 1 Sonal M Manohar , Amol A Padgaonkar , Archana Jalota-Badhwar , Vinay Sonawane , Maggie J Rathos , Sanjay Kumar2 and Kalpana S Joshi3* Abstract Background: Hypoxia-inducible factor-1 (HIF-1) is a master regulator of the transcriptional response to hypoxia. It is essential for angiogenesis and is associated with tumor progression and overexpression of HIF-1a has been demonstrated in many common human cancers. Therefore, HIF-1a is one of the most compelling anticancer targets. Methods: To identify HIF-1a inhibitors, luciferase reporter gene assay under hypoxia and normoxia was used. Detailed studies such as western blotting, RT-PCR, immunofluorescence were carried out to elucidate its mechanism of action. Antiangiogenic activity of P3155 was demonstrated by migration assay and tube formation assay. Efficacy study of P3155 was performed on PC-3 xenograft model. Results: P3155 showed specific HIF-1a inhibition with IC50 of 1.4 μM under hypoxia. It suppressed HIF-1a expression as well as PI3K/Akt pathway and abrogated expression of HIF-1-inducible gene viz. vascular endothelial growth factor (VEGF). P3155 in combination with HIF-1a siRNA showed significant synergistic effect. In addition, it demonstrated significant in vivo efficacy and antiangiogenic potential in prostate cancer cell lines. Conclusion: We have identified a novel HIF-1a inhibitor P3155 that also modulates PI3K/Akt pathway, which may contribute to its significant in vitro and in vivo antitumor

您可能关注的文档

文档评论(0)

118zhuanqian + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档